1579 Results

People

  1. Cheung
    Cheung
  2. Wolchok
    Wolchok
  3. Postow
    Postow
  4. Hellmann
    Hellmann
  5. Adusumilli
    Adusumilli
  6. Old
    Old
  7. Livingston
    Livingston
  8. Motzer
    Motzer
  9. Slovin
    Slovin
  10. Houghton
    Houghton

Groups

  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)
  7. Center for Hematologic Malignancies (221)
  8. Surgery (221)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (191)
  10. Melanoma Disease Management Team (186)
  1. "immunotherapy"
Formats
  1. Journal Article (1126)
  2. Review (243)
  3. Editorial (60)
  4. Meeting Abstract (57)
  5. Book Section (30)
  6. Guidelines (28)
  7. Research Letter (14)
  8. Conference Paper (9)
  9. Correspondence (7)
  10. Miscellaneous (5)
Groups
  1. Department of Medicine (882)
  2. Solid Tumor Oncology Division (646)
  3. GSK Faculty (409)
  4. Hematologic Malignancies, Division of (373)
  5. Sloan Kettering Institute Postdocs (252)
  6. Melanoma and Immunotherapeutics Service (227)

More Groups

People
  1. Jedd Wolchok (107)
  2. Nai-Kong Cheung (71)
  3. Michael Postow (67)
  4. Matthew Hellmann (53)
  5. Prasad Adusumilli (39)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (69)
  2. 2024 (160)
  3. 2023 (135)
  4. 2022 (134)
  5. 2021 (129)
  6. 2020 (102)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (117)
  2. Journal of Thoracic Oncology (55)
  3. Clinical Cancer Research (41)
  4. Annals of Oncology (35)
  5. Cancer Immunology, Immunotherapy (29)
  6. Cancer (28)

More Publications

Publishers
  1. Elsevier Inc. (242)
  2. Biomed Central Ltd (139)
  3. Springer (103)
  4. Wiley Blackwell (83)
  5. American Association for Cancer Research (69)
  6. Oxford University Press (67)

More Publishers

Results (1579)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atezolizumab plus PEGPH20 versus chemotherapy in advanced pancreatic ductal adenocarcinoma and gastric cancer: MORPHEUS phase Ib/II umbrella randomized study platform
    Journal Article

    Ko, A. H.; Kim, K. P.; Siveke, J. T.; Lopez, C. D.; Lacy, J.; O'Reilly, E. M.; Macarulla, T.; Manji, G. A.; Lee, J.; Ajani, J.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Review of cancer therapies for the perioperative physician
    Review

    Dabo-Trubelja, A.; Gottumukkala, V.
    Perioperative Medicine (2023)

    Fulltext@MSK | Save
  • Survival of locally advanced MSI-high gastric cancer patients treated with perioperative chemotherapy: A retrospective cohort study
    Journal Article

    Vos, E. L.; Maron, S. B.; Krell, R. W.; Nakauchi, M.; Fiasconaro, M.; Capanu, M.; Walch, H. S.; Chatila, W. K.; Schultz, N.; Ilson, D. H.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • TGFβ control of immune responses in cancer: A holistic immuno-oncology perspective
    Review

    Nixon, B. G.; Gao, S.; Wang, X.; Li, M. O.
    Nature Reviews Immunology (2023)

    Fulltext@MSK | Save
  • Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
    Journal Article

    Rojas, L. A.; Sethna, Z.; Soares, K. C.; Olcese, C.; Pang, N.; Patterson, E.; Lihm, J.; Ceglia, N.; Guasp, P.; Chu, A.; more...
    Nature (2023)

    Fulltext@MSK | Save
  • Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
    Research Letter

    Asdourian, M. S.; Jacoby, T. V.; Shah, N.; Otto, T.; Thompson, L. L.; Dee, E. C.; Reynolds, K. L.; Semenov, Y. R.; Chen, S. T.
    Journal of the American Academy of Dermatology (2023)

    Fulltext@MSK | Save
  • Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
    Journal Article

    Hamid, O.; Hassel, J. C.; Shoushtari, A. N.; Meier, F.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P. C.; Mauch, C.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Plain language summary of the MajesTEC-1 study of teclistamab for the treatment of people with relapsed or refractory multiple myeloma
    Review

    Moreau, P.; van de Donk, N. W. C. J.; Nahi, H.; Oriol, A.; Nooka, A. K.; Martin, T.; Rosinol, L.; Karlin, L.; Benboubker, L.; Mateos, M. V.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save
  • A plain language summary of the CheckMate 649 study: Nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus
    Review

    Janjigian, Y. Y.; Shitara, K.; Moehler, M.; Garrido, M.; Salman, P.; Wyrwicz, L.; Yamaguchi, K.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; more...
    Future Oncology (2023)

    Fulltext@MSK | Save